Peptide-drug conjugates Peptide drug delivery systems are engineered to effectively transport therapeutic peptides within the body, aiming to improve their bioavailability, stability, and targeted action.Protein and Peptide Drug Delivery These advanced systems are crucial for overcoming the inherent challenges associated with peptide therapeutics, such as poor oral absorption, rapid degradation in the body, and limited tissue penetration2023年8月16日—The applications ofpeptidesin biomedicine continue to expand as researchers explore their potential in areas like immunotherapy, genedelivery, wound healing .... By utilizing innovative carrier technologies, peptide drug delivery systems facilitate the precise delivery of peptides for a wide range of applications, including the treatment of chronic diseases, cancer, and genetic disorders作者：D Tesauro·2019·被引用次数：251—In this review, we focus on the design and the characterization ofdrug delivery systemsusingpeptide-based carriers..
Peptides, composed of short chains of amino acids, play vital roles in numerous biological processes and have emerged as a significant class of therapeutic agents. Their high specificity and potency offer distinct advantages over traditional small molecule drugsSmart Peptide-Based Drug Delivery - CD Bioparticles. However, their therapeutic potential is often hampered by their susceptibility to enzymatic degradation and their inability to cross biological barriers like the gastrointestinal tractTargeting Peptides: The New Generation of Targeted Drug .... This is where sophisticated peptide drug delivery systems become indispensable.作者：B Todaro·2023·被引用次数：69—Peptides can act as targeting molecules, analogously to oligonucleotide aptamers and antibodies. They are particularly efficient in terms of production and ... These systems are designed to protect the peptide payload from degradation, control its release rate, and direct it to specific target sites within the body, thereby maximizing therapeutic benefit while minimizing off-target effects and systemic toxicity.
The field of peptide drug delivery is characterized by continuous innovation, with researchers exploring diverse strategies and materials to create more effective and patient-friendly delivery solutions.作者：JJ Du·2025·被引用次数：23—Peptide-based delivery systemsoffer various advantages such as low immunogenicity, a high safety profile, and controlled dosage of administration (32, 33). The ... Among the most promising approaches are:
* Nanoparticle-Based Delivery Systems: These systems utilize nanoscale carriers, such as liposomes, polymeric nanoparticles, and micelles, to encapsulate peptides. Nanoparticles offer several advantages, including enhanced stability, improved cellular uptake, and the potential for targeted delivery through surface functionalization. For instance, self-assembled peptide nanomaterials are being developed through various design strategies to create sophisticated drug delivery vehicles.
* Hydrogels and Biomaterials: Hydrogels, three-dimensional networks capable of absorbing large amounts of water, are being employed for sustained and controlled release of peptide drugs.CD Formulation is one of the leaders indeveloping innovative drug delivery systems for proteins/peptides. We excel in encapsulating proteins/peptides in ... Their biocompatibility and tunable properties make them suitable for various administration routes, including injection and topical application. Transdermal drug delivery systems using hydrogels are also being investigated to bypass the first-pass metabolism associated with oral administrationThis document provides an overview ofprotein and peptide drug delivery. It begins with definitions of proteins and peptides and descriptions of protein ....
* Peptide-Based Carriers: In a self-referential approach, peptides themselves are engineered to act as carriers for other therapeutic molecules, including other peptides, nucleic acids, and even toxic drugs.Peptide-Based Drug Delivery Systems - CD Bioparticles These functional peptides can be conjugated with therapeutic agents, forming peptide-drug conjugates or smart drug delivery systems that respond to specific physiological cues.
* Oral Delivery Technologies: Overcoming the poor oral bioavailability of peptides remains a significant challenge. However, innovative platform technologies, such as Peptelligence™, are emerging that are clinically proven to enable the oral delivery of peptides, addressing a major unmet need for more convenient administration routes.
The development of advanced peptide drug delivery systems offers numerous benefits. These include: enhanced therapeutic efficacy, reduced dosing frequency, improved patient compliance, and the potential to deliver a wider range of peptide therapeutics that were previously limited by delivery challenges. Applications span a broad spectrum of diseases, from metabolic disorders and cardiovascular conditions to cancer immunotherapy and genetic diseases. For example, peptide-based DDSs are frequently employed to deliver anti-cancer drugs and nucleic acid-based therapies, offering a controlled release mechanism. They also possess favorable biocompatibility, biochemical, and biophysical properties, often with a lack of inherent toxicity.
Despite significant advancements, challenges remain in the widespread clinical adoption of peptide drug delivery systems.作者：D Berillo·2021·被引用次数：129—Peptide-baseddrug delivery systemshave many advantages when compared to synthetic systems in that they have better biocompatibility, biochemical and ... These include ensuring long-term stability of the delivered peptides, achieving precise targeting to specific cells or tissues, and developing cost-effective manufacturing processes. Furthermore, the development of effective delivery systems for protein and peptide therapeutics continues to be an active area of research.Peptide-Based Drug Delivery Systems - CD Bioparticles Future efforts will likely focus on developing "smart" delivery systems that can respond to the disease microenvironment, personalized delivery solutions, and more efficient routes of administration, such as oral and inhaled delivery. The continued exploration of peptide-based carriers and their characterization is paving the way for the next generation of targeted and effective peptide therapeutics作者：A Jain·2013·被引用次数：188—They also have developedhydrogels and transdermal drug delivery systemsfor peptidal drug delivery. A receptor-mediated delivery system is another attractive ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.